Novartis sells parts of Sandoz U.S. to Aurobindo Pharma for $900 million

Novartis AG said on Thursday it would sell the dermatology and generic U.S. oral solids portfolios of Sandoz U.S. to India's Aurobindo Pharma Ltd for $900 million, as the Swiss drugmaker looks to focus on higher growth areas.

from Reuters: Money News https://ift.tt/2M1c7Jl
via IFTTT

• Tweet
• Share
• Share
• Share
• Share